<DOC>
	<DOCNO>NCT00388440</DOCNO>
	<brief_summary>To evaluate safety immunogenicity GSK Biologicals ' live attenuate MMR vaccine ( Priorix ) local population Singapore . The vaccine administer single dose healthy child ( 12-18 month age ) blood sample collect two time point ( vaccination vaccination ) .</brief_summary>
	<brief_title>Assess GSK Biologicals ' MMR Vaccine ( Priorix ) When Given Healthy Children Age 12 18 Months Singapore .</brief_title>
	<detailed_description />
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female infant 12 18 month age time vaccination Written inform consent obtain parent guardian subject . Free obvious health problem establish medical history clinical examination enter study . Use investigational nonregistered drug vaccine study vaccine ( ) study period within 30 day precede dose study vaccine Previous vaccination mumps and/or rubella History , intercurrent , measles , mumps , and/or rubella disease Known exposure measles , mumps rubella within 30 day prior start study Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Mumps</keyword>
	<keyword>Singapore</keyword>
	<keyword>Rubella</keyword>
	<keyword>Measles</keyword>
</DOC>